Editors-in-Chief: Amedeo Lonardo, Youfei Guan
Median time to first editorial decision: 6 days

Metabolism and Target Organ Damage

Articles

Most Recent | Most Viewed | Most Downloaded

Short-term L-arabinose administration alleviates MASLD by remodeling gut microbiota and activating hepatic ATF5-dependent mitochondrial unfolded protein response

Open Access Original Article DOI: 10.20517/mtod.2025.179 17 Dec 2025
Views: Downloads:
Download PDF

Sex and gender differences in MASLD: pathophysiological mechanisms, clinical implications, and future directions

Open Access Review DOI: 10.20517/mtod.2025.131 17 Dec 2025
Views: Downloads:
Download PDF

Prevalence and incidence of obesity among children and adolescents in Guangdong: a prospective analysis from 2019-2022

Open Access Original Article DOI: 10.20517/mtod.2025.130 17 Dec 2025
Views: Downloads:
Download PDF

Beyond the liver: targeting the hepatic microenvironment and multi-organ networks for innovative MASH therapy

Open Access Review DOI: 10.20517/mtod.2025.163 15 Dec 2025
Views: Downloads:
Download PDF

Association between wearable device usage and obesity transition in children and adolescents: a nationwide longitudinal study

Open Access Original Article DOI: 10.20517/mtod.2025.116 11 Dec 2025
Views: Downloads:
Download PDF

Liver fibrosis in nonalcoholic fatty liver disease patients: noninvasive evaluation and correlation with cardiovascular disease and mortality

Open Access Review DOI: 10.20517/mtod.2022.23 30 Jan 2023
Views: Downloads:
Download PDF

Metabolic primary liver cancer in adults: risk factors and pathogenic mechanisms

Open Access Review DOI: 10.20517/mtod.2022.38 30 Mar 2023
Views: Downloads:
Download PDF

MASLD, MAFLD, or NAFLD criteria: have we re-created the confusion and acrimony surrounding metabolic syndrome?

Open Access Perspective DOI: 10.20517/mtod.2024.06 26 Feb 2024
Views: Downloads:
Download PDF

Coming soon.

59 Editorial Board Members of Metabolism and Target Organ Damage Named among World's Top 2% of Scientists for 2025
An Impressive Debut with an IF of 3.9, Officially Ranked in Q2
Replay now available - uncover key perspectives from leading experts.
On MASLD Mechanisms, Copper-Based Therapies, and the Future of Liver Disease Management.
Replay now available - uncover key perspectives from leading experts.

Coming soon.

Metabolism and Target Organ Damage
ISSN 2769-6375 (Online)
Follow Us

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/